Telehealth and Telecare News since 2005 ...

Hims & Hers expands to Ireland, France, and Germany, and adds to UK. Announced yesterday, the ambitious strategic acquisition of Zava, a similar online direct to consumer provider of telemedicine ...

After this Editor’s call for breaking up UnitedHealth Group –two more views, for your consideration (as Rod Serling used to say before we entered ‘The Twilight Zone’). MedCityNews examines The No Good ...

30 May 2025 Brrrr….it’s unofficially summer as we leave May behind. Our big article this week is your Editor’s think-piece on breaking up UnitedHealth Group in order to save it–and healthcare. We also ...

Another review/meta-analysis confirms that GLP-1 weight off doesn’t stay off. A University of Oxford systemic review and meta-analysis of 130 full texts, distilled to 11 studies with 6,370 ...

One of our Perspectives contributors, Yosi Health, is seeking candidates for two positions: Demand Generation Manager This role combines lead generation with marketing analysis, coordination with ...

Breaking up is hard to do. But should be done if UHG wants to survive and thrive. Our proposition: UnitedHealth Group has become a victim of its own giantism, conflicts, and focus on financials–and ...

Partnerships and add-ons are much in the news this week. Hims & Hers isn’t worrying about GLP-1 drug sourcing. Neither are Ro and LifeMD. All three made a deal with Novo Nordisk on providing branded ...

Medical device company Masimo may not be able to rid itself entirely of its meddlesome former CEO, Joe Kiani. In fact, if a court awards him the shares exercised under his various employment ...

Short takes: Veradigm’s interim CEO departing, Blue Shield CA breached 4.8M members’ PHI to Google, advice on expanded M&A premarket notification rules (You can’t blame that CEO for ankling! And Blue ...

Starting with international health tech developments… South Australia Health has rolled out Altera Digital Health’s Sunrise Electronic Medical Record (EMR) and Patient Administration System (PAS). The ...

Transcarent closes Accolade buy, changes its game. Transcarent’s $621 million acquisition of Accolade was wrapped up in record time (two months from announcement). This takes the Nasdaq-listed ...